Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other ...

While Enhertu (trastuzumab deruxtecan, T-DXd) is an established treatment for patients with HER2-low metastatic breast cancer (mBC), there has been limited information about how well it works for ...

Explore new strategies for treating resistant lung cancer. Discover how blocking growth hormone receptors may improve ...

Considered the natural "hunger hormone," ghrelin could be the key to preventing debilitating chronic constipation experienced by people living with Parkinson's disease, University of Queensland ...

Understanding the Testosterone-Acne Connection If you thought acne breakouts were only a teenage problem, think again.

Many breast cancer drugs block estrogen receptors inside cancer cells. Blocking the receptors early in disease progression staves off metastasis. But most patients with advanced disease eventually ...

Progesterone Receptor Positive (PR+) breast cancer is a distinct biological subtype of hormone receptor positive breast cancer. This type of cancer grows in response to progesterone, a hormone that is ...

CDK 4/6 inhibitors (CDK4/6i) remain part of the standard first-line treatment for patients with hormone receptor–positive metastatic breast cancer, offering demonstrable improvements in both ...

Estrogen, the major female ovarian hormone, can trigger nerve impulses within milliseconds to regulate a variety of physiological processes. At Baylor College of Medicine, Louisiana State University ...